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The mammary gland is a very dynamic organ that undergoes continuous remodeling. The critical regulators of this
process are not fully understood. Here we identify the microRNA cluster miR-424(322)/503 as an important
regulator of epithelial involution after pregnancy. Through the generation of a knockout mouse model, we found
that regression of the secretory acini of the mammary gland was compromised in the absence ofmiR-424(322)/503.
Mechanistically, we show that miR-424(322)/503 orchestrates cell life and death decisions by targeting BCL-2 and
IGF1R (insulin growth factor-1 receptor). Furthermore, we demonstrate that the expression of this microRNA
cluster is regulated by TGF-b, a well-characterized regulator of mammary involution. Overall, our data suggest
a model in which activation of the TGF-b pathway after weaning induces the transcription of miR-424(322)/503,
which in turn down-regulates the expression of key genes. Here, we unveil a previously unknown, multilayered
regulation of epithelial tissue remodeling coordinated by the microRNA cluster miR-424(322)/503.
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The mammary gland is a very dynamic organ that
passes through continuous tissue remodeling during
the female lifetime (Howard and Gusterson 2000; Ip
and Asch 2000; Macias and Hinck 2012). The appearances
of distinct placodes containing mammary epithelial
precursors initiate the limited ingrowth of a rudimentary
ductal tree during embryogenesis that undergoes exten-
sive expansion at puberty in the female breast. In adult
females, side branches and lobulo–alveolar structures
are in a continuous cycle in response to the cycling
ovarian hormones. During pregnancy, secretory alveoli
develop in response to specialized hormones, forming
a very dense lactiferous epithelial tree that invades
almost the entire mammary fat pad. During weaning,
regression of this architecture occurs, leading to
alveoli and secretory duct collapse (a process known
as involution).
 2014 Llobet-Navas et al. This article is distributed exclusively by
Cold Spring Harbor Laboratory Press for the first six months after
the full-issue publication date (see http://genesdev.cshlp.org/site/misc/
terms.xhtml). After six months, it is available under a Creative Commons
License (Attribution-NonCommercial 4.0 International), as described at
http://creativecommons.org/licenses/by-nc/4.0/.
14These authors contributed equally to this work.
15Corresponding author
E-mail jose.silva@mssm.edu
Article published online ahead of print. Article and publication date are
online at http://www.genesdev.org/cgi/doi/10.1101/gad.237404.114.
GENES & DEVELOPMENT 28:765–782 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/14; www.genesdev.org 765
 Cold Spring Harbor Laboratory Press on March 3, 2015 - Published by genesdev.cshlp.orgDownloaded from 
During the last two decades, key details about the mo-
lecular mechanism and regulation of the massive remod-
eling that occurs during mammary gland involution
have emerged (Watson 2006; Stein et al. 2007; Watson
and Kreuzaler 2011). It is well established that involution
occurs in two distinct phases according to its reversibil-
ity. The first 48 h after weaning are characterized by
apoptotic cell death without changes in acini architec-
ture. Molecularly, this step involves both the intrinsic
and the extrinsic apoptotic pathways and is modulated by
the expression levels of members of the pro- and anti-
apoptotic BCL-2 family. A few signaling pathways have
been identified as upstream modulators of apoptosis,
some of the most relevant being TGF-b, IGF (insulin
growth factor), LIF, NF-kB, and STAT-3. Cues for these
pathways converge to regulate Akt/PKB, which in turn
balances cell life and death decisions. The second phase,
2 d after initiation of involution, is characterized by the
collapse of the alveolar structure and degradation of the
supportive extracellular matrix, which is mediated by
metalloproteases.
Despite our current knowledge of mammary gland
development, our understanding of the contribution of
miRNAs to this process is in its infancy. MicroRNAs
(miRNAs) are small noncoding RNAs, ;22 nucleotides
(nt) in length, with critical roles inmultiple aspects of cell
biology and organism physiology (Bartel 2004, 2009).
miRNAs post-transcriptionally regulate gene expression
mainly by targeting mRNAs for cleavage, translational
repression, and mRNA destabilization. A very limited
number of studies have identified and validated miRNAs
with a role in any aspect of normal mammary gland bi-
ology (Avril-Sassen et al. 2009; Tanaka et al. 2009; Ucar
et al. 2010; Yang et al. 2010; Cui et al. 2011; Le Guillou
et al. 2012), and even fewer have studied their function in
vivo (Ucar et al. 2010; Le Guillou et al. 2012).
Here we identified the miR-424(322)/503 cluster as
an important regulator of involution. To investigate the
processes influenced by this cluster in vivo, we generated
a knockout mouse model in whichmiR-424(322)/503 was
deleted. Although knockout mice were fully viable, de-
tailed analyses of mammary gland development revealed
a delayed pattern of involution after pregnancy. The study
of miR-424(322)/503 targets identified a group of genes
with a key role in apoptosis (BCL-2) and insulin signaling
(IGF1R [IGF-1 receptor]). Importantly, we also demon-
strated that the changes in the expression of these targets
mediated by the miR-424(322)/503 cluster impact cell
death as well as the activity of key signal transduction
pathways (AKT and ERK1/2) in vitro and in vivo. Further-
more, our studies linked the expression of the cluster to
TGF-b, which plays a well-known role in mammary gland
involution (Faure et al. 2000; Nguyen and Pollard 2000;
Stein et al. 2007). Overall, our studies suggest a model in
which the expression of a primary transcript containing
the miR-424(322)/503 cluster is up-regulated during in-
volution via TGF-b exposure. Once processed, these
mature miRNAs are part of the mechanisms that induce
involution by down-regulating the expression of key
components of signal transduction and cell death.
Results
The miRNA cluster 424(322)/503 is up-regulated
during mammary gland involution in mammary
epithelial cells
In order to investigate the landscape of miRNAs
expressed in the mammary gland epithelium, we per-
formed miRNA high-throughput sequencing (HTP-seq)
studies on six different stages of development (puberty,
estrus, diestrus, pregnancy [15 d], lactation [10 d], and
involution [3 d]) (Fig. 1A). Estrus and diestrus represent
the two most different stages that occur during periodic
ovarian cycles. Estrus is characterized by the presence of
primary and secondary epithelial ducts with very little
alveolar budding. On the other hand, the diestrus stage is
characterized by a higher abundance of alveolar buds.
Involution of the mammary gland after pregnancy is the
phase where the most dramatic changes occur. We thus
decided to investigate the miRNAs that were specifical-
ly expressed in the mammary epithelial cells during
this period. Of 1281 described mature miRNA sequences
(miRBase release-19), ;200 were expressed in at least one
developmental stage (complete miRNA profile will be
reported elsewhere) (data not shown). When we searched
for miRNAs preferentially up-regulated during involu-
tion, we found a group of 12 miRNAs with a Z-score$1.5
(Fig. 1A). Additionally, we studied by quantitative RT–
PCR (qRT–PCR) the expression of these miRNAs across
a series of 15 different organs. Interestingly,miR-424(322)
was expressed at the highest levels almost exclusively in
involuting mammary epithelium, while the rest of the
miRNAs in the list were expressed at higher levels in
several other organs (Fig. 1B). Furthermore,miR-424(322)
was also the most up-regulated miRNA transitioning
from lactation to involution (72 h) (Fig. 1C). Nine of the
12 miRNAs that we found preferentially up-regulated
during involution have been previously studied during
mammary development (Avril-Sassen et al. 2009). While
we used HTP-seq of purified mammary epithelial cells to
evaluate miRNA expression, the Avril-Sassen et al. (2009)
study used a bead-based flow cytometric microarray
platform and whole mammary gland RNA extraction
without purification. This difference complicates the
direct comparison of the data; however, we noticed that
six of the nine overlapping miRNAs between both
studies showed similar expression patterns (Supplemen-
tal Fig. S1A).
miR-424(322) belongs to the miR-16 family (Liu et al.
2008; Finnerty et al. 2010). Somemembers of this miRNA
family have been previously shown to target known
modulators of cell cycle and apoptosis, which are funda-
mental pathways during involution. We observed that
other members of the miR-16 family were expressed in
the mammary epithelium; however, their steady-state
levels did not increase significantly during involution
(72 h) (Supplemental Fig. S1B). Remarkably, evolutionary
studies on themiR-16 family have revealed that while all
vertebrates studied to date express miR-15a, miR-15b,
miR-16,miR-103, andmiR-107, onlymammals are known
to expressmiR-195,miR-424(322),miR-497,miR-503, and
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Figure 1. Up-regulation of the miRNA cluster 424(322)/503 in the epithelium during the involution of the mammary gland. (A)
Schematic representation of the strategy performed to identify stage-specific miRNAs in the epithelium of the mammary gland and
lists of miRNAs differentially up-regulated during involution. Samples were collected at puberty (1 mo), estrus, diestrus, pregnancy (15 d),
lactation (10 d), and involution (3 d). (B) Tissue-specific expression analysis of involution-related miRNAs and their relative expression
in the involuting mammary epithelium; n = 5. (C) Fold up-regulation of involution-related miRNAs when compared with lactating
mammary glands; n = 5. (D) Estimation of the number of molecules of miR-322 per cell during mammary gland development; n = 3.
(E) Distribution of the normalized number of reads ofmiR-424(322) andmiR-503 per sample after miRNA HTP-seq analysis in a cohort
of 800 primary breast tumors (The Cancer Genome Atlas [TCGA] breast cancer). See also Supplemental Figure S1.
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miR-646 (Finnerty et al. 2010), suggesting a specialized
function.
Prompted by these data, we decided to investigate in
more detail the role and regulation ofmiR-424(322) in the
remodeling of involuting mammary epithelium. A more
detailed analysis of the expression of the mature miR-
424(322) during early (24 h after weaning) and late (3 d
after weaning) involution confirmed that it peaks during
late involution (Supplemental Fig. S1C). miR-424(322) is
located in chromosome X and in close proximity (;380
base pairs [bp]) to miR-503 in both humans and mice.
Both miRNAs have been proposed to be expressed as
a cluster (Forrest et al. 2010), and, in fact, we were able to
retrotranscribe a transcript containing both miRNAs
(Supplemental Fig. S1D). Interestingly, miR-503 was
filtered out in our HTP-seq analysis because of its low
expression levels, suggesting that miR-424(322) is pref-
erentially processed from the precursor miRNA (pre-
miRNA). By titrating chemically synthesized mature
miRNAs, we estimated that the number of molecules of
mature miR-322 is about a few hundred per cell but
increases to a few thousand (fivefold to 10-fold) during
involution (Fig. 1D; Supplemental Fig. S1E). Although the
mature form of miR-503 also increased proportionally
during involution, the steady-state levels of miR-503
were about a log of magnitude lower than levels of miR-
322 (Supplemental Fig. S1F). By comparing the number of
reads corresponding to both miRNAs in the HTP-seq data
generated by The Cancer Genome Atlas (TCGA) breast
cancer study from >800 samples (Fig. 1E; https://tcga-data.
nci.nih.gov/tcga), we also confirmed that higher levels of
miR-424(322) are maintained in humans. Finally, HTP-
seq data available in the miRBase database (http://www.
mirbase.org) as well as published studies in normal ovarian
tissue (Ahn et al. 2010) confirmed a comparable relative
miR-424(322)/miR-503 ratio of expression. Taken together,
these data suggest that higher levels of mature miR-
424(322) compared with miR-503 are well preserved
between humans and mice. The reason for the unbiased
levels between these two miRNAs is unclear. In this
regard, it has been previously reported that miR-503 is
usually unstable and that this instability is mediated by
the seed region and the 39 end (Rissland et al. 2011).
miR-424(322)/503 knockout mice present defects
in mammary gland involution and display
alveoli hyperplasia after pregnancy
To study the role of the miR-424(322)/503 in the mam-
mary epithelium, we generated a knockout mouse model
using zinc finger nuclease (ZFN; Sigma) technology
(Fig. 2A; Urnov et al. 2010). Two ZFNs cutting upstream
of and downstream from the cluster were engineered and
injected into 400 fertilized oocytes. These oocytes were
injected into recipient C57BL/6 females, and 54 viable
pups were born. Males and females were born at a Men-
delian ratio. The genotype of these animals revealed that
50% of the males carried a mutated miR-322/503 allele.
In females, 30% were heterozygous, and 8.3% had both
alleles mutated. Due to the nature of the mechanisms
involved in the repair of the double-strand breaks gener-
ated by the ZNFs, there were varying sizes of the deletion
in mutant alleles. These deletions ranged from 22 nt
to larger fragments of almost 1 kb containing the two
miRNAs (Supplemental Fig. S2A,B). For our studies, we
used mice containing deletions of both mature miRNAs
(alleles 7A and 38) (Fig. 2A). As expected, both knockout
alleles showed the same phenotype (see below). Conse-
quently, in this study and for simplification, we do not
make any distinction between them and use the general
term miR-424(322)/503 knockout. We also obtained
alleles where only one of the two miRNAs was deleted.
Interestingly, when we analyzed the expression levels of
the remaining miRNA, we observed that these levels
were severely reduced to barely detectable levels (Fig. 2B).
This result suggests that the sequence/structure of the
miR-424(322)/503 primary transcript is essential for proper
generation of mature miRNAs.
Phenotypically, knockout pups were identical to the
wild type in appearance, size, and weight. We did not
observe any evident differences between knockout and
wild-type animals during the first 2 mo of life. At a later
age, knockout mice presented with a higher body weight
due to increased white fat content (characterization of
this phenotype will be reported elsewhere).
Next, we concentrated our studies on the mammary
gland epithelium during the different phases of develop-
ment. A systematic study of the female epithelialmammary
tree was done by comparing whole-mount preparations
stained with carmine red and quantifying the area occu-
pied by epithelial cells and adipocytes (Chapman et al.
1999; Tiffen et al. 2008). Acini morphology and organ-
ization were studied using hematoxyilin/eosin (H&E)
staining, and basal (cytokeratin 5) and luminal (cytoker-
atin 18) markers were studied using immunohistological
techniques. These studies revealed no major differences
in the organization (size, length, number, and basal/
luminal marker distribution) of the ducts and lobules
during puberty and during estrus/diestrus of nulliparous
animals at an early age (up to 3 mo) (Supplemental Fig.
S2C–E). Older virgin knockout females presented a few
slightly enlarged terminal ductal lobular units (TDLUs)
containing two to three times more acini than age-
matched wild-type counterparts (Fig. 2C). Interestingly,
parous females displayed mammary glands with multifo-
cal, larger TDLUs compatible with alveoli hyperplasia
(Fig. 2D).
Expression of the miR-424(322)/503 cluster increases
during involution after pregnancy. Thus, it is plausible
that the observed phenotype in parous animals has its
origin at this stage. Our studies during pregnancy and
involution revealed that during pregnancy, secretory acini
in knockout animals displayed normal morphological and
functional (milk-producing) characteristics (Supplemental
Fig. S2F,G). In addition, we also observed comparable
morphological features at early involution (24 h after
weaning) between knockout and wild-type animals (Sup-
plemental Fig. S2H,I). At late involution (3 d after wean-
ing), wild-type females displayed massive destruction
of the lobular epithelium, which led to the absence of
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Figure 2. miR-424(322)//503/ knockout (KO) mice show delayed post-lactation mammary gland involution and alveolar
hyperplasia. (A) Modeling of miR-424(322)//503/ double-knockout mice by using the ZFN technology generates multiple deleted
alleles. (B) qRT–PCR expression values for miR-424(322) and miR-503 in wild-type animals and miR-424(322)//503/ knockout
mice with different deleted alleles. (C) Representative carmine red staining performed on old nulliparous female mammary glands
reveals discrete enlarged terminal ductal lobular units (TDLUs). (D) In parous females, TDLUs progress into enlarged multifocal
structures compatible with alveolar hyperplasia. (E) Representative stainings of involuting mammary glands at 72 h. H&E, cytokeratin 5,
cytokeratin 18, and caspase-3 stainings reveal drastic lobular epithelium death in wild-type (WT) mice, while the mammary
epithelium of miR-424(322)/503 knockout animals still presents well-organized and structured acini. (F) The graph shows
quantification of caspase-3-positive cells per acini for immunostainings (between 80 and 150 acini were counted per condition). See
also Supplemental Figure S2.
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recognizable acini structures; in contrast, knockout fe-
males presented lobules withmorphologically well-struc-
tured acini (Fig. 2E; Supplemental Fig. S2H,I). Remark-
ably, apoptosis was reduced 3 d after weaning in knockout
animals, as indicated by fewer cells displaying activated
caspase-3 immunostaining (Fig. 2E,F; Supplemental
Fig. S2J).
It is important to mention that both knockout alleles
(7A and 38) were crossed with wild-type animals for six
generations (a 98.5% clean background) to confirm the
association between the genotypemiR-424(322)/503 knock-
out and the phenotype. As expected, the phenotype segre-
gated with the knockout alleles.
The miRNA cluster 424(322)/503 targets the key
regulators of mammary gland involution, BCL-2
and IGF1R
The biological functions of miRNAs are mediated by
their ability to attenuate the expression of targetedmRNAs.
Thus, we investigated the targets of the miR-424(322)/503
cluster. Computational prediction of targets based on
seed sequence conservation (Lewis et al. 2005) as well
as nonconserved sites (Grimson et al. 2007) is a widely
used strategy to identify miRNA targets. We used the
TargetScan algorithm (http://www.targetscan.org), which
has been shown to have one of the highest specificities in
preselecting putative target genes (Shirdel et al. 2011).
miR-424(322) and miR-503 have almost identical seed
sequences and belong to the samemiRNA family (Fig. 3A).
Thus, it is not surprising that the predicted target overlap
between both miRNAs is very high [>90% of the pre-
dicted targets conserved in mammals for miR-503 are
included in the list for miR-424(322)] (Supplemental
Fig. S3A). Computational predictions of miRNA targets
result in hundreds, if not thousands, of candidates. In
order to reduce this number of genes, we exploited the
fact that up-regulation of the targeting miRNA reduced
the expression level of targets with potent binding side
sequences (Bartel 2009; Guo et al. 2010). We transduced
MCF-10A, an immortalized but nontransformed human
mammary epithelial cell (HMEC) line, with lentiviruses
expressing the miR cluster or a control vector and com-
pared their expression profiles after 48 h. As expected, this
study showed a strong statistically significant reduction in
the expression of predicted target genes (P < 1034) (Fig. 3B).
Pathway analysis (Ingenuity) of the predicted targets that
showed reduction in mRNA levels identified a group of
genes involved in cell cycle, apoptosis, TGF-b, and canon-
ical ERK/AKT signal transduction pathways (Supplemen-
tal Fig. S3B,C). Since these pathways are key regulators of
mammary gland involution (Neuenschwander et al. 1996;
Nguyen and Pollard 2000; Schwertfeger et al. 2001; Stein
et al. 2007; Macias and Hinck 2012), we decided to fur-
ther study a series of these putative targets by following a
systematic approach.
First, we assessed the ability of the predicted target
sites of these genes to regulate the expression of a reporter
gene. We cloned a portion of the untranslated regions
(UTRs) containing the predicted miR cluster-binding sites
for 20 genes related to the above-mentioned pathways
downstream from a luciferase reporter gene (Luc-UTR).
We then cotransduced 293T cells with the corresponding
Luc-UTR reporter, a renilla luciferase expression vector
lacking any UTR used for normalization purposes, and
a plasmid expressing the miR-424(322)/503 cluster. The
UTRs of 14 out of 20 candidates showed a statistically
significant reduction of the Luc-UTR reporter in the pres-
ence of the construct expressing the miR-424(322)/503
cluster (Fig. 3C).
Next, we performed additional validation using photo-
activatable ribonucleoside-enhanced cross-linking im-
munoprecipitation (PAR-CLIP) of the RNA-induced si-
lencing complex (RISC) (Hafner et al. 2010). PAR-CLIP
experiments were performed in MCF-10A control cells
and anMCF-10Avariant transduced with lentivirus vector
expressing the miR-424(322)/503. After CLIP, qRT–PCR
was used to quantify the levels of captured mRNA for
the 14 selected targets. Our data revealed a statistically
significant enrichment for six of 14 targets, four of
them showing more than twofold enrichment (CDC25A,
BCL-2, IGF1R, and CCNE1) (Fig. 3D). Interestingly, there
was a positive correlation between the enrichment in the
PAR-CLIP assay and the Luc-UTR reporter assay. Because
the expression of BCL-2 (Metcalfe et al. 1999) and IGF1R
(Modha et al. 2004) has been found to be down-regulated
during involution and because apoptosis and insulin
signaling are well-known regulators of this process, we
decided to further investigate these two genes. Additionally,
we also studied CCNE1, as it has previously been shown
to be targeted by this miR cluster. Thus, we next mutated
the predicted conserved miR-424(322)/503-binding sites
in the Luc-UTR constructs for these three genes. Modi-
fication of the sequence complementary to the miRNA
seed region in the mRNA UTR reverted completely the
reduction of luciferase signal after up-regulation of the
miR-424(322)/503 cluster (Fig. 3E).
Next, we analyzed the impact of themiR-424(322)/503
on the levels of the endogenous proteins. In order to use
the most biologically relevant model, we engineered a
MCF-10A variant to up-regulate the expression of the
miRNA-424(322)/503 using a doxycycline (Dox)-inducible
system [MCF-10A-424(322)/503miR-Dox]. Importantly,
this system allowed us to up-regulate miR-424(322) and
miR-503 to levels comparable with those observed in
involuting mouse mammary epithelial cells (MMECs)
(Supplemental Fig. S3D). Up-regulation of themiR cluster
in MCF-10A-424(322)/503miR-Dox clearly attenuated
the expression levels of BCL-2 and IGF1R, but the effect
on CCNE1 expression was modest (Fig. 3F). Finally, we
studied the expression levels of these three targets in
primary MMECs during development as well as in telo-
merase (Tert)-immortalized mammary epithelial cell lines
from wild-type and knockout animals. Western blot stud-
ies revealed an evident down-regulation of Igf1r and Bcl-2
during involution that occurs at the highest peak of the
mature miR-424(322) and miR-503 expression, while no
major effect was seen in Ccne1 (Fig. 3G; Supplemental Fig.
S3E). Remarkably, both primary involuting MMECs and
Tert-immortalized miR-424(322)/503 knockout mammary
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Figure 3. BCL2 and IGF1R are bona fide targets ofmiR-424(322)/503. (A) The illustration represents the multistep strategy designed to
identify miR-424(322)/503 targets. (B) Cumulative distribution of predicted miR-424(322)/503 targets and nontargets when their
expression levels from control and miR-424(322)/503-up-regulated MCF-10A cells are compared. (C) Cloning of the 39 UTR and
subsequent 39 UTR-luciferase assays of the selected candidates shows differential targeting activity by miR-424(322)/503 (n = 5) that
was further filtered by PAR-CLIP expression analysis via qRT–PCR (n = 5; shown in D). (E) miRNA-binding site mutagenesis and
luciferase assays were performed in the most relevant candidates to prove themiR-424(322)/503-binding specificity. (F) MCF-10A cells
were lentivirally transduced with an inducible plasmid expressing the miR-424(322)/503 and treated with Dox for 5 d. Western blot
analysis showed a decrease in the endogenous protein levels of miR-424(322)/503 targets IGF1R2 and BCL2 but not in CCNE1 (n = 5).
(G) Western blot studies of purified mouse mammary epithelium show that IGF1R and BCL2 protein levels decrease during the
transition from lactation to involution in wild-type (WT) animals and that post-lactation miR-424(322)/503 knockout animals as well
as Tert-immortalized miR-424(322)/503 knockout cells (Tert-KO) present higher expression of these targets than their wild-type
counterparts (shown in H). A minimum number of five animals were analyzed. See also Supplemental Figure S3.
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epithelial cells presented consistently higher protein levels
of these proteins than wild-type counterparts. Again no
significant changes were observed in Ccne1 (Fig. 3H).
Expression of the miR-424(322)/503 cluster modulates
IGF-1 signal transduction and apoptosis
While the data described above clearly showed the ability
ofmiR-424(322)/503 tomodulate the expression of BCL-2
and IGF1R, it was crucial to determine whether this
regulation was biologically relevant.
IGF1R is the bona fide receptor for IGF-1 (Pollak 2012).
IGF-1 binding activates the receptor kinase, leading to
autophosphorylation and phosphorylation of downstream
substrates and resulting in the activation of two main
signaling pathways, the PI3K–AKT/PKB and the Ras–
MAPK pathways. To test the role of miR-424(322)/503
in these pathways, IGF-1 was added to starved MCF-10A-
424(322)/503miR-Dox cells after the miR cluster was
induced by the addition of Dox to the medium. Down-
regulation of IGF1R protein levels mediated by induc-
tion of the miR cluster led to a weaker response to IGF-1
stimulation, as demonstrated by reduction in the levels of
phospho-IGF1R (Tyr1135 and Tyr1131), phospho-AKT
(Ser473), and phospho-ERK1/2 (Thr202/Tyr204) (Fig. 4A).
Importantly, wild-type phosphorylation levels in all three
proteins were restored when a nontargetable version of
IGF1R lacking the 39 UTR was exogenously expressed
(Fig. 4B; Supplemental Fig. S4A). To complement our
studies, we performed a similar analysis with Tert-im-
mortalizedMMECs and primaryMMECs. These revealed
that miR-424(322)/503 knockout cells, which present
higher levels of Igf1r, were more sensitive to IGF-1 stimu-
lation than their wild-type counterparts (Fig. 4C,D). Alto-
gether, these data demonstrate that modulation of IGF1R
by miR-424(322)/503 affects the response to IGF-1 and its
downstream canonical signaling.
BCL-2 is the founding member of the Bcl-2 family of
apoptosis regulator proteins (Colitti 2012), and its key
role in the intrinsic apoptosis pathway is well established.
BCL-2’s prosurvival abilities are largely due to its ability
to control mitochondrial membrane permeability by in-
hibiting proapoptotic proteins. Thus, we tested whether
the ability to undergo apoptosis was affected by themiR-
424(322)/503 cluster. Apoptosis in MCF-10A-424(322)/
503miR-Dox cells was induced by exposure to different
chemotherapeutic agents (cisplatin and paclitaxel). Up-
regulation of themiR-424(322)/503 cluster by addition of
Dox significantly increased apoptosis induced by pacli-
taxel and cisplatin as shown by Annexin-V FACS analy-
sis, caspase-3, and PARP cleavage, while no differences
were observed in control cells (Fig. 4E; Supplemental Fig.
S4B–D). Importantly, transduction of a BCL-2 mRNA
that lacks the 39 UTR eliminated this effect (Fig. 4F;
Supplemental Fig. S4E–H). As previously done for ERK/
AKT signaling studies, we also studied the response to
apoptotic stress in our Tert-immortalized MMECs. We
found that miR-424(322)/503 knockout cells, which
present higher levels of Bcl-2, were significantly more
resistant to apoptosis than wild-type counterparts (Fig.
4G; Supplemental Fig. S4I,J). Overall, these data demon-
strate that modulation of BCL-2 by themiR-424(322)/503
cluster affects the stress-induced apoptotic response.
Characterization of the 424(322)/503 promoter
pri-miR and its modulation by TGF-b
Tomechanistically understand the regulation of themiR-
424(322)/503 in the mammary epithelium, we studied
the genomic organization of the locus. As a first approach,
we took advantage of the publicly available information
contained in the University of California at Santa Cruz
genome (UCSC) browser (http://genome.ucsc.edu). The
close proximity between miR-424(322) and miR-503
suggests that the primary transcript containing both
miRNAs exists as a cluster. Interestingly, a noncoding
RNA (MGC16121) is described in the reference sequence
gene bank whose 59 precisely matches the predicted
sequence of the precursor of miR-424(322) [pre-miR-
424(322)] after pre-miR has been excised by the nucle-
oprocessor complex from the primary transcript (Fig. 5A).
A review of the track displaying maps of chromatin
states generated by the Broad Institute/Massachusetts
General Hospital ENCODE group using chromatin im-
munoprecipitation (ChIP) and HTP-seq (ChIP-seq) revealed
a region located ;2 kb upstream of the miR-424/503 clus-
ter and strongly enriched in histone marks related to
an active promoter (H3K4me2, H3K4me3, H3K9ac, and
H3K27ac) in HMECs (Fig. 5A). Specifically, there was
enrichment in a histone mark associated with transcrip-
tion elongation (H3K36me3) just after the termination
of the active promoter marks and spanning ;5–6 kb
in a region containing the miRNA cluster (Fig. 5A).
Remarkably, a comparable histone mark pattern was also
found in the majority of the cell lines analyzed, with the
exception of B cells (Supplemental Fig. S5A). In embry-
onic stem cells, this putative promoter seems to be poised
for active transcription, as it presents both active and
negative histone marks (Supplemental Fig. S5B; Bernstein
et al. 2006). Finally, FOX2 CLIP-seq (CLIP coupled with
HTP-seq) used to study RNAs associated with the splic-
ing regulator FOX2 showed that the H3K36me3-enriched
region was, in fact, transcribed in the 59–39 orientation,
consistent with a primary transcript starting at the pu-
tative promoter upstream of the miR cluster (Fig. 5A).
In order to obtain further insights regarding the tran-
scriptional regulation of the locus, we searched for con-
served sequence motifs in the putative promoter region
(the ;2-kb region enriched in the above-mentioned his-
tone marks). Multiple alignments of 28 vertebrate species
and measurements of evolutionary conservation using a
hidden Markov model-based method (phastCons) (Pollard
et al. 2010) identified several motifs conserved in verte-
brates and mammals (Fig. 5B). Interestingly, one of these
motifs represented two SMAD-binding boxes (Fig. 5B;
Johnson et al. 1999). SMADs are bona fide components of
the TGF-b and BMP pathways (Massague et al. 2005).
Significantly, TGF-b ligands have well-known roles in ep-
ithelial mammary gland morphogenesis (Nguyen and
Pollard 2000; Stein et al. 2007; Macias and Hinck 2012).
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Upon TGF-b ligand binding to its receptor, receptor-
regulated SMAD-2 and SMAD-3 (R-SMADs) are activated
by phosphorylation, heterodimerize with SMAD-4, and
are then shuttled to the nucleus, where they act as
transcription factors. R-SMADs are weak transcriptional
activators and commonly cooperate with additional tran-
scriptionalmodulators, such as E2Fs (Massague et al. 2005).
Remarkably, a highly conserved region containing two
E2F-binding motifs is located in close proximity (;100
bases) downstream from the SMAD-3-binding site.
TGF-b ligands have a key role during mammary epi-
thelial development, mainly as potent inhibitors of pro-
liferation (Howard and Gusterson 2000; Macias and Hinck
2012). During involution, expression of TGF-b ligands in
themammary gland, especially TGF-b3, is induced as soon
as 3 h after forced weaning, and levels of TGF-b3 continue
Figure 4. InducedmiR-424(322)/503 desensitizes cells to IGF-1 and primes cells to undergo apoptosis. (A) Dox-inducedmiR-424(322)/
503 targets endogenous IGF1R, causing desensitization to IGF-1 stimuli, as shown by Western blot. Cells were treated with Dox for 5 d,
starved with 0.5% horse serum overnight, and subsequently treated with 50 ng/mL IGF-1 for the specified time points. (B) Engineered
pT-424(322)/503 MCF-10A cells stably expressing a nontargetable form of IGF1R (pLX-IGF1R) are able to overcome IGF-1 desensitization
caused by Dox-induced miR-424(322)/503. pLX-EV MCF-10A cells stably expressing an empty vector control. (C) Tert-immortalized
knockout (Tert-KO) epithelial cells show consistent higher sensitivity to IGF-1 stimulation, as shown by Western blot. (D) Western
blots showing increased activation of p-AKT and p-ERK in purified miR-424(322)/503 knockout involuting mammary epithelial cells
compared with their wild-type (WT) counterparts. (E) pT-424(322)/503 cells treated with Dox display higher sensitivity to apoptosis
induced by 100 ng/mL paclitaxel (PTX) and 10 mg/mL cisplatin, as shown by quantification of cell death by Annexin-V staining and
FACs analysis (top panel) and analysis of active caspase-3 and cleaved PARP by Western blot (bottom panel). MCF-10A cells were treated
with Dox and subsequently exposed to PTX for 24 h. (F) Expression of a BCL2 cDNA devoid of its 39 UTR (pLOC-BCL2) blocks apoptotic
cell death induced by PTX. (G) Tert-immortalized knockout cells exert higher resistance to PTX, as shown by Annexin-V, caspase-3, and
PARP studies. All the experiments were performed in triplicate. See also Supplemental Figures S4 and S5.
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Figure 5. Genomic organization of miR-424(322)/503 locus unveils transcriptional regulation mediated by TGF-b. (A) UCSC-
extracted genomic locations of miR-424(322) and miR-503 and putative regulatory elements located upstream in HMECs, including
histone marks of transcriptionally active chromatin (H3K4me2, H3K4me3, H3K9ac, and H3K27ac), transcriptional silencing or
repression (H3K27me3), and elongation (H3K36me3) as well as marks of elongation and splicing events, represented by genome-wide
FOX2 CLIP-seq. The presence of additional regulatory regions such as CpG islands is also depicted. (B) Representation of the
conservation status of miR-424(322), miR-503, and the upstream regulatory regions using a vertebrate and placental mammal Markov
model. Using this method, 28 vertebrate species were aligned to assess conservation status. Magnification of a small conserved region
located upstream (highlighted in red) identifies two conserved SMAD-binding motifs. (C) Analysis by miRNA expression arrays of
MCF-10A treated with 10ng/mL TGF-b for 24, 48, and 72 h. (D) Results were further validated by qRT–PCR (top panel) and in situ
hybridization (bottom panel). For in situ hybridization, MCF-10A cells transduced with a construct expressing the cluster miR-
424(322)/503 were used as a positive control. (E) TGF-b-dependent regulation of miR-424(322) and miR-503 was verified in other
HMEC lines (MCF-12A and 184B5), HuMECs, and primary Tert-immortalized MMECs. Cells were treated with 10 ng/mL TGF-b1 for
48 h. (F) Expression analysis by qRT–PCR of miR-15/16 family members in MCF-10A cells upon treatment with 10 ng/mL TGF-b for
several days. (G) TGF-b-dependentmiR-424(322) andmiR-503 expression was demonstrated by transfecting MCF10A cells with siRNA
against SMAD4. Scrambled siRNAs and siRNAs against GFP were used as negative controls. The expression of bona fide TGF-b targets
(top panel) and miR-424(322) and miR-503 (bottom panel) was performed by qRT–PCR. See also Supplemental Figure S5.
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to increase during the following hours to remain high for
several days (Faure et al. 2000; Nguyen and Pollard 2000).
Furthermore, expression of TGF-b type II receptor (Faure
et al. 2000) and the nuclear internalization of Smad-4
(Nguyen and Pollard 2000) also occur in the mammary
epithelium at about the same time. Although the role of
TGF-b3 is not fully understood, in vivo evidence from
transgenic mice expressing Tgf-b3 under the b-lactoglobin
promoter or expressing a dominant-negative form of the
Tgf-b receptor-II in the mammary gland (MMTV-DNIIR)
as well as from animals where Tgf-b3 knockout mam-
mary epithelial cells were orthotopically transplanted
demonstrates the importance of Tgf-b signaling during
the early and late involution phases (Nguyen and Pollard
2000; Gorska et al. 2003). Based on the above information,
we hypothesized that exposure to TGF-b ligands during
involution up-regulates the expression of miR-424(322)/
503, which in turn modulates key players of cell cycle,
apoptosis, and IGF-1 signaling.
The mammary cell line MCF-10A is a widely used
model to study TGF-b response in mammary epithelial
cells (Iavarone and Massague 1997; Karakas et al. 2006).
Despite being null for the INK4B gene, these cells re-
tain the ability to arrest after being exposed to TGF-b.
(Iavarone and Massague 1997). To study the regulation of
themiR-424(322)/503 cluster, we exposedMCF-10A cells
to TGF-b1 and, using miRNA microarrays, tracked the
expression of 799 human miRNAs (Sanger miRbase re-
lease 10.1) through time. BothmiR-424(322) andmiR-503
emerged as the top TGF-b1-up-regulated miRNAs (Fig.
5C). qRT–PCR of the mature miRNAs and in situ
hybridization experiments confirmed themicroarray data
(Fig. 5D) and showed that the observed up-regulation was
time- and dose-dependent (Supplemental Fig. S5C). In-
duction of miR-424(322)/503 was not restricted to MCF-
10A cells, and, although it was less pronounced, we also
observed induction in two additional nontransformed
human cell lines (MCF-12A and 184B5), in primaryHMECs
(HuMECs), and in MMECs immortalized with TERT
(Fig. 5E).
As mentioned above, TGF-b3 is a TGF-b ligand with
a key role during involution (Nguyen and Pollard 2000).
Thus, we also tested its ability to induce the expression of
the miRNA cluster. Our data showed that comparable
levels of miR-424(322) and miR-503 up-regulation were
induced with both TGF-b1 and TGF-b3 (Fig. 5F). Inter-
estingly, none of the other miR-16 family members were
induced after TGF-b1 and TGF-b3 exposure.
To evaluate the role of the canonical TGF-b pathway in
the regulation of miR-424(322)/503, we knocked down
SMAD4 before exposing MCF-10A cells to TGF-b1
(Fig. 5G). In knockdown cells, the induction of bona fide
TGF-b targets such as SMAD7, P21, CTCF, ATF3, and
PAI-1 as well as miR-424(322) and miR-503 was signifi-
cantly reduced. Next we investigated which of the
R-SMADs was involved in the regulation ofmiR-424(322)/
503. Both SMAD2 and SMAD3 are activated during in-
volution and when MCF-10A cells are exposed to TGF-b
(Supplemental Fig. S5D). Thus, we individually silenced
SMAD2 and SMAD3 (Supplemental Fig. S5E) and evalu-
ated the up-regulation of the mature miR-423(322) and
miR-503 as well as the pri-miR cluster. Our studies clearly
demonstrate that SMAD3 is the R-SMAD responsible
for the up-regulation of the pri-miR-424(322)/503 and the
production of themiRmature forms uponTGF-b exposure
(Supplemental Fig. S5F,G).
To further confirm the role of TGF-b in regulating the
expression of miR-424(322)/503, we performed ChIP
assays to investigate the presence of SMAD4 in the endog-
enous putative promoter. To pursue this aim, we created
a MCF-10A cell line where HA-tagged SMAD4 protein
was constitutively expressed in MCF-10A cells. After en-
suring that the exogenously introduced SMAD4 behaved as
the endogenous protein did (both were shuttled into the
nucleus in the presence of TGF-b) (Supplemental Fig. S6A),
we used this cell line to perform ChIP with anti-HA
antibodies. These studies revealed that SMAD4 was en-
riched in the putative miR-424(322)/503 promoter after
TGF-b exposure at levels comparable with the bona fide
TGF-b target PAI-1 (Fig. 6A). Importantly, the strongest
enrichment happened in the region near the SMAD4-
binding site.
To evaluate the role of the putative SMAD4-binding
site in the up-regulation of the miRNA cluster upon
TGF-b exposure, we first engineered a reporter construct
containing an ;5.4-kb region upstream of the miRNA
cluster followed by the GFP sequence (Fig. 6B). This
reporter was integrated into the genome of MCF-10A
cells by lentiviral delivery to create a pri-miR reporter cell
line (MCF-10A-pri-miR-reporter). Reverse transcription
using oligonucleotides complementary toGFP allowed us
to study the transcript resulting exclusively from the
reporter without interference of endogenous pri-miR (see
the Materials and Methods). Upon addition of TGF-b
to theMCF-10A-pri-miR-reporter cells, a clear increase in
the transcription of the reporter was observed (Fig. 6C).
Importantly, when we mutagenized the SMAD4-binding
site, this increase was abrogated.
Next, we further characterized the pri-miR transcript
controlled by this promoter. First, we identified the tran-
scription start site (TSS) by performing 59 rapid amplifi-
cation of cDNA end (RACE). By using a specific primer
located upstream of the miR cluster just before the region
enriched in promoter-specific histone marks (;300 bp
downstream from the SMAD4-binding site) for the re-
verse transcription step, we identified a TSS located
downstream from the E2F-binding sites (Fig. 6D; Supple-
mental Fig. S6B). Interestingly, the addition of TGF-b
shifted the TSS 181 nt upstream, which suggests the pres-
ence of an alternative promoter. As expected, we were
able to amplify a region expanding from the miRNA
cluster to the TSS by using overlapping PCRs (Supple-
mental Fig. S6C). qRT–PCR amplification and in situ
hybridization confirmed the up-regulation of the pri-
miRNA by TGF-b exposure (Fig. 6E; Supplemental Fig.
S6C). As expected, the pri-miRNAwas detected by in situ
hybridization at the mammary epithelium of involuting
mammary glands (3 d) (Supplemental Fig. S6D). Notably,
kinetic studies of the pri-miRNA, pre-miRNA, and ma-
ture miRNA levels after addition of TGF-b revealed that
miR-424/503 regulates mammary involution
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Figure 6. Characterization of the miR-424(322)/503 promoter, pri-miR-424(322)/503, and transcriptional regulation by TGF-b in vivo. (A)
MCF-10A cells stably expressing HA-tagged SMAD4 or a control empty vector were treated with 10 ng/mL TGF-b for 3 h, and ChIP was
performed using an anti-HA antibody. The quantification of genomic DNA enrichment was performed using specific primers surrounding the
promoter. The putative SMAD-binding site is indicated by a red square. Quantification of DNA enrichment in the PAI-1 gene promoter was
used as a positive control, while b-Actin and Gapdh were used as negative controls. (B) A schematic illustration obtained from the UCSC
genome database showing the localization ofmiR-424(322) andmiR-503 and the upstream putative 5.4-kb promoter region containing either
the wild-type or mutated SMAD-binding site that was cloned into a reporter vector, as explained in the text. (C) MCF-10A cells were
transduced with either the wild-type or mutated promoters and treated with or without 10 ng/mL TGF-b, and the promoter activity was
analyzed by qRT–PCR. (D) Representation of the proposedmiR-424(322)/503 cluster promoter region containing the SMAD-binding site and
the alternative TSSs identified by 59 RACE in the presence and absence of TGF-b. (E) Expression kinetics of pri-miR-424(322)/503 after
treatment of MCF-10A cells with 10 ng/mLTGF-b for the specified time points by qRT–PCR using specific primers surrounding the pre-miR-
424(322) and pre-miR-503 (left) or by in situ hybridization using a probe against pri-miR-424(322)/503 (right). (F) qRT–PCR analysis showing
that increased maturemiR-424(322) andmiR-503 levels after treatment of MCF-10A cells with 10 ng/mLTGF-b coincide with a decrease in
pre-miR-424(322) and pre-miR-503, respectively. (G) After inhibition of TGF-b signaling in vivo by the administration of the specific inhibitor
LY2109761, mammary glands were examined 72 h after weaning for the presence of secretory acini by H&E and for epithelial density by
whole-mount carmine red staining. Additionally, mammary epithelial cells were purified, andmilk protein production was evaluated by qRT–
PCR using specific primers for a-lactalbumin and b-casein genes. (H) Inhibition of the activation of the TGF-b pathway, shown by Western
blot and immunohistochemistry for activated phospho-SMAD2/3, abrogates the transcription of pri-miR-424(322)/503 during involution, as
shown by qRT–PCR. See also Supplemental Figure S6, E and F, for a similar study using the TGF-b inhibitor LY2157299.
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the increase in pri-miRNA and pre-miRNA happens first
and that generation of mature miRNAs leads to a reduc-
tion of the pri-miRNA and pre-miRNA (Fig. 6E,F). This
could be due to the cleavage and degradation of the pri-
miRNA after the pre-miRNA is excised, the existence of
a negative regulatory feedback loop, or a combination of
both mechanisms.
Finally, to test that the regulation ofmiR-424(322)/503
by TGF-b occurs in vivo during involution, we individu-
ally treated lactating females with two different specific
inhibitors of TGF-b receptor I and II with demonstrated
activity in vivo (LY2109761 and LY2157299) (Melisi et al.
2008; Bouquet et al. 2011; Calon et al. 2012; Bhola et al.
2013) and analyzed the induction of the miR cluster.
When lactating females were pretreated with these inhib-
itors starting 24 h before weaning, these animals showed
an evident inhibition of involution 3 d after weaning, as
indicated by carmine red and H&E staining of the mam-
mary gland and qRT–PCR levels of milk proteins (Fig. 6G;
Supplemental Fig. S6E). Importantly, due to the inhibi-
tion of TGF-b signaling, they also presented a strong
reduction in the levels of pri-miR-424(322)/503 (Fig. 6H;
Supplemental Fig. S6F).
Discussion
Despite the established role of a variety of extrinsic and
intrinsic signals regulating mammary gland development
(Howard and Gusterson 2000; Macias and Hinck 2012),
a restricted number of studies have identified and vali-
dated miRNAs with a role in any aspect of normal
mammary gland biology (Avril-Sassen et al. 2009; Tanaka
et al. 2009; Ucar et al. 2010; Yang et al. 2010; Cui et al.
2011; Le Guillou et al. 2012), and even fewer have studied
their function using transgenic animal models (Ucar et al.
2010; Le Guillou et al. 2012). Here we unveiled the
miRNA cluster miR-424(322)/503 as an important regu-
lator of the massive reorganization that occurs in the
mammary epithelium after pregnancy. Furthermore,
through the generation of a knockout mouse model, we
characterized mechanistically its role and regulation.
Among the 12 identified miRNAs,miR-424(322) showed
the largest fold increase between lactation and involu-
tion. Although this miRNA has been studied in the
context of monocyte differentiation (Rosa et al. 2007;
Forrest et al. 2010) and endothelial cell regulation (Ghosh
et al. 2010; Nakashima et al. 2010; Kim et al. 2013), a
potential role inmammary epithelial architecture remod-
eling has not yet been described. The characterization of
the mammary epithelium ofmiR-424(322)/503 knockout
females during development revealed a defect during
involution. To understand the role of miR-424(322)/503
in this biological context, we considered two pertinent
questions: (1) Which are the relevant targets modulated
by the cluster in themammary epithelium? (2) How is the
pri-miR regulated?
Through our comprehensive studies in vitro and in
vivo, we identified BCL-2 and IGF1R as robust target
genes of the miR-424(322)/503 cluster in the mammary
epithelium. Interestingly, our data did not validate previous
data reporting CCNE1 as a target of this miRNA cluster
(Forrest et al. 2010; Nakashima et al. 2010). Since the
relevance of the different miRNA targets is context-
dependent (Liu and Kohane 2009; Inui et al. 2010), it is
important to mention that we used HMECs for our
studies and achieved mature miRNA expression levels
comparable with the observed during involution in vivo.
Notably, when we augmented by lentiviral transduction
the intracellular levels of the mature miRNAs several
fold (>10 times) over the levels found in vivo, we observed
a reliable reduction of CCNE1 protein (Supplemental
Fig. S3F). Finally, no major changes were observed in
CCNE1 protein levels from lactation to involution. Thus,
our data illustrate the importance of the biological
context in identifying relevant miRNA targets for differ-
ent processes, and, consequently, we do not consider
CCNE1 a relevant target of the miR-424(322)/503 in the
context of mammary epithelial involution and TGF-b
exposure.
During the last two decades, key details about the mech-
anism and regulation of mammary gland involution have
been identified (Stein et al. 2007). The use of genetically
modified mice with gain or loss of function has pro-
vided evidence regarding the implication of Bcl-2 and
Igf1r in this process. The Igf1/Igf1r axis plays critical roles
in multiple steps of mammary development (Hynes and
Watson 2010). During involution, IGF signaling has been
found to be inhibited by down-regulation of Igf1r (Modha
et al. 2004) and up-regulation of insulin-like growth
factor-binding protein 5 (Igfbp-5) (Allan et al. 2004).
Importantly, the effect of IGF signaling in life or death
fate decisions has been related to its effect on the PI3K–
AKT/PKB and the Ras–MAPK pathways (Allan et al.
2004; Stein et al. 2007). In accordance with this, in-
volution has been found to be inhibited in transgenic
animals with constitutively active Akt (Schwertfeger
et al. 2001; Ackler et al. 2002). BCL-2 family members
are also involved in regulating cellular fate after the
pregnancy cycle (Colitti 2012). Levels of proapoptotic
Bak and Bad increase during lactation, reaching their
peak during involution. In contrast, anti-apoptotic Bcl-
W and Bcl-2 are strongly down-regulated at the onset of
apoptosis (Metcalfe et al. 1999). In the proposed model,
mammary epithelial cells are poised for apoptosis with
higher levels of the death effectors but are prevented from
triggering apoptosis by anti-apoptotic Bcl-2 family pro-
teins until involution, when prosurvival gene expression
levels decline (Metcalfe et al. 1999; Stein et al. 2007;
Colitti 2012). In agreement with this view, enforced
expression of Bak induces rapid mammary apoptosis
(Metcalfe et al. 1999), while high levels of Bcl-2 have
been shown to potently regulate mammary epithelial cell
survival and inhibit alveolar cell apoptosis during in-
volution (Jager et al. 1997; Schorr et al. 1999).
By understanding the signals that initiate the transcrip-
tional up-regulation of the miR cluster, we uncovered its
regulation by TGF-b. As TGF-b ligands have well-known
roles in epithelial mammary glandmorphogenesis (Nguyen
and Pollard 2000; Stein et al. 2007), this information
provided us with a potential link between the induction
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of involution and the up-regulation of the miR cluster. It
is interesting to discuss that the R-SMAD that controls
the up-regulation of the miR-424(322)/503, SMAD3, has
been found to control not only transcription but also
miRNA processing in a SMAD4-independent function
(Davis et al. 2008, 2010). Thus, a question is whether this
also applies for the production of mature miR-424(322)
and miR-503. SMAD3 has been found to interact with
DROSHA and affect miRNA maturation by binding to
a conserved 5-base motif (SBE; 59-CAGAC-39) present in
the pri-miRs. However the pri-miR-424(322)/503 cluster
transcript does not contain this binding element. Addi-
tionally, individual silencing of both SMAD3 and SMAD4
completely abrogated the up-regulation of both pri-miR-
424(322)/503 and individual mature forms. Thus, at this
point, transcriptional up-regulation seems to be a critical
step, and additional studies will be required to clarify a
potential miRNA processing function of pri-miR-424(322)/
503 by SMAD3.
Mechanistically, our data suggest a model (Fig. 7) in
which milk stasis after weaning rapidly induces the
expression of TGF-b3. Activation of the TGF-b pathway
induces the transcription of pri-miR-424(322)/503. This
primary transcript is processed to preferentially generate
mature miR-424(322), which in turn down-regulates the
expression of components of the involution response,
IGF1R and BCL-2. Our data have unveiled a previously
unknown multilayered regulation of epithelial tissue
remodeling coordinated by the miRNA cluster miR-
424(322)/503.
Our work may also have implications regarding tumor
biology because several members of the miR-16 family
have been involved in human malignancies (Liu et al.
2008; Aqeilan et al. 2010). All miR-424(322)/503 targets
studied here have been shown to be associated with
human cancers as oncogenes (Yip and Reed 2008; Pollak
2012). The ability of miR-424(322)/503 to modulate tar-
get expression raises the question of whether it is also
Figure 7. Proposed mechanistic model of miR-424(322)/503 function. During mammary gland involution, critical events dictate the
reorganization of the mammary epithelial cell compartment. TGF-b, a well-known player, governs involution in part by inducing the
expression of a miRNA primary transcript containing the miR-424(322)/503 cluster. The generation of the mature miRNAs, mainly
miR-424(322), reduces the expression of targets such as IGF1R and BCL2. This reduction results in attenuation of IGF signaling and
sensitization to apoptosis, leading the epithelial cells toward cell death during involution. The above highlights the miR-424(322)/503
cluster as a critical regulator of mammary gland homeostasis through its ability to dictate cell life and death decisions through
balancing proliferation, survival, and cell death pathways.
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involved in breast tumorigenesis. Our data in this regard
reveal that knockout animals accumulate alveoli hyper-
plasia, but we did not observe tumor development in
animals followed up to 1 yr of age. Longer periods of follow-
up, multiple pregnancies, or both may be necessary to
generate full cell transformation in these animals. In-
terestingly, miR-424(322)/503 is located in a chromoso-
mal region that has been recently identified to present
significant deletions in ;8% of hormone receptor-posi-
tive breast cancers (Dvinge et al. 2013). Furthermore, the
promoter region that we identified is placed on a CpG
island that could be targeted by hypermethylation as
a potential mechanism to down-regulate the expression
of the miRNAs during transformation. AsmiR-424(322)/
503 is located in the silenced part of the X chromosome,
a single inactivation event is enough to fully abrogate its
expression. Interestingly, it has been recently reported
that suppressed miR-424(322) expression contributes to
the progression of cervical cancer (Xu et al. 2013).
Additional research will be necessary to fully define the
potential role of miR-424(322)/503 in breast tumorigen-
esis. In this regard, our work describing the biological role
ofmiR-424(322)/503 during involution and its regulation
establishes the basis for future studies.
Materials and methods
Cell culture
Cell lines were obtained from the American Type Culture
Collection. Normal breast epithelial MCF-10A and MCF-12
cells were cultured at 37°C/5%CO2 in DMEM/Ham’s F-12
supplemented with 10% penicillin/streptomycin, 20 ng/mL
EGF, 10 mg/mL insulin, 100 ng/mL cholera toxin, 500 ng/mL
hydrocortisone, and 5% horse serum. HuMECs (Life Technolo-
gies, no. A10565) were grown according to instructions and
reagents provided by the manufacturer. 184B5 cells were grown
in MEGM medium (Lonza/Clonetics, no. CC-3150) supple-
mented with 1 ng/mL cholera toxin. Phoenix cells were grown
in DMEM–10% fetal bovine serum and 10% penicillin/strepto-
mycin at 37°C/5%CO2.
TGFb1 and TGFb3 were purchased from Sigma (nos. T7039
and T5425, respectively). Human recombinant IGF1 was pur-
chased from PROSPEC (no. CYT-216). Cisplatin (no. P4394) and
paclitaxel (no. T7402) were both from Sigma.
miRNA extraction and HTP-seq
To perform mature miRNA and pre-miRNA expression analysis
by qRT–PCR, RNA was purified using the miRVANA miRNA
isolation kit (Ambion, no. AM1561) according to the instruc-
tions provided. Reverse transcription was performed on 50 ng of
RNA using the miRNA reverse transcription kit (Roche, no.
4366596). miRNA deep sequencing was conducted at the Columbia
University Genome Center’s core facility (http://genomecenter.
columbia.edu) using the Illumina platform. RNA sequencing
(RNA-seq) was performed at HiSeq single reads with a depth of
coverage of 20 million reads per sample.
Luciferase reporter assays
39 UTRs of specific target genes were cloned downstream from
the luciferase reporter in the pMIR-REPORT vector (Life Tech-
nologies, no. AM5795M) by PCR from human genomic DNA
using restriction enzymes. Relative luciferase units (RLUs) were
measured using the Dual-Glo luciferase assay system (Promega,
no. E2949). For a detailed description, see the Supplemental
Material.
Mouse generation and LY2109761 treatment
To generate single miR-424(322) and miR-503 or double-knock-
out mice, we used ZNF (Sigma; for a detailed description, see the
Supplemental Material). To inhibit TGF-b signaling during in-
volution, lactating wild-type and miR-424(322)//miR-503/
double-knockout females were pretreated by oral gavage twice
daily with 50 mg/kg LY2109761 (Selleckchem) for 24 h before
weaning. Thereafter, mice were treated again by oral gavage
twice daily with 50 mg/kg LY2109761 for 1 and 3 d. Mice were
sacrificed, and mammary glands were dissected as mentioned
previously. All experiments were performed under the Institu-
tional Animal Care and Use Committee (IACUC) guidelines.
PAR-CLIP analysis
A PAR-CLIP assay to measure AGO2 enrichment in miR-
424(322)/503 mRNA targets was performed as described pre-
viously (Hafner et al. 2010). Briefly, cells were pretreated with
50 mM4-thiouridine (Sigma, no. T4509) overnight and cross-linked
at 150 mJ/cm2 at 365 nm UV on ice. Immunoprecipitation was
performed using an anti-AGO2 antibody (Abnova, no. H00027161-
M01) overnight at 4°C. RNA was extracted using the miRVANA
miRNA isolation kit, and retrotranscribed RNA was subjected to
analysis by qRT–PCR using specific primers.
Quantification of the number of miR-424(322) and miR-503
molecules
The number of molecules was estimated using chemically
synthesized RNA oligonucleotides that mimic in sequence
miR-424(322) and miR-503. RNA oligonucleotides were pre-
pared in serial dilutions corresponding to 1 pg of miRNA per
microliter, 0.1 pg of miRNA per microliter, 0.01 pg of miRNA
per microliter, and 1 fg of miRNA per microliter. One microliter
of each dilution was retrotranscribed in parallel with 50 ng of our
samples. The number of molecules per cell was estimated by
considering a ratio of 10 pg of RNA per cell and integrating the
experimental Ct values into the standard values obtained with
the commercial oligonucleotides.
Flow cytometry and cell viability
All flow cytometry experiments were performed on a BD
FacsCalibur cell analyzer using the CellQuest Pro software onMac
OSX. To analyze apoptosis induced by cisplatin and paclitaxel,
we performed the Annexin-V staining following the FITC
Annexin-V apoptosis detection kit guidelines (BD Pharmingen,
no. 556570). For a detailed description, see the Supplemental
Material.
Whole-mount preparations and immunohistochemistry
To prepare whole-mount carmine red staining, mammary glands
were fixed in 4% paraformaldehyde for 1 h, stained with carmine
red (Sigma, no. C1022) overnight at room temperature, and
ultimately dehydrated and fixed in xilol. To perform immuno-
histochemical analysis, formalin-fixed paraffin-embedded sam-
ples were deparaffinized and rehydrated. Peroxidase inactivation
and antigen retrieval were achieved by incubating samples in 1%
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H2O2 and citric buffer. The antibodies used were Ki67 (1:200;
Abcam, no. ab15580), anti-cytokeratin 18 antibody (1:300; Abcam,
no. ab668), anti-cytokeratin 5 (1:1000; Covance, no. PRB-160P),
cleaved caspase-3 (1:500; Cell Signaling, no. 9664), and p-SMAD2/3
(1:100; Cell Signaling, no. 9510).
Gene expression and miRNA expression arrays
For gene expression and miRNA expression arrays, MCF-10A
cells were treated with TGFb, and RNA was extracted using
RNeasy and miRVANA extraction kits, respectively, and labeled
using the LowInput QuickAmp labeling kit (Agilent, no. 5190-
2331). RNAs were hybridized on a human GE 4x44K v2 micro-
array kit (Agilent, no. G4845A) and a human miRNA V2 oligo
microarray (Agilent, no. G4470B), respectively. Gene expression
array data have been uploaded and are available in the Gene
Expression Omnibus database.
ChIP
MCF-10A untreated and TGFb cells were cross-linked with 11%
formaldehyde solution for 10 min at room temperature, lysed,
and sonicated using a Bioruptor Standard sonication device
(Diagenode, no. UCD-200 TM; see the Supplemental Materi-
al). HA-SMAD4 immunoprecipitation was performed using
the DynaMag-2 magnetic particle concentrator (Invitrogen, no.
123.21D), protein G Dynabeads (Invitrogen, no. 100.03D), and
an anti-HA antibody (Roche, no. 11867423001) overnight at 4°C
on a rotator. Thereafter, samples were collected and washed, and
phenol/chloroform/isoamyl alcohol extraction using Phaselock
tubes (Prime, no. 2302840) was performed to isolate DNA. DNA
enrichment was analyzed by qRT–PCR using specific primers.
Data are presented as the D-normalized values between SMAD4-
HA [D (TGFb-treated)  (untreated)]  EV [D (TGFb-treated) 
(untreated)]. For a detailed description, see the Supplemental
Material.
In situ hybridization
Briefly, probes against pri-hsa-miR-424(322)/503 were created
from human genomic DNA by PCR using specific oligonucleo-
tides and were obtained by T7-driven in vitro RNA synthesis.
Probes against maturemiR-424(322) andmiR-503were purchased
from Exiqon (catalog no. 38195-08), and the assay was visualized
using a tyramide signal amplification method (PerkinElmer,
NEL741001KT). For a detailed description, see the Supplemental
Material.
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